| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.073 | 0.2 |